To include your compound in the COVID-19 Resource Center, submit it here.

MMPIs fail again for British Biotech

British Biotech (LSE:BBG; BBIOY) said that in a Phase III trial of its marimastat oral

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE